Search results
Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
Medscape· 14 hours agoNSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 day ago“Our top priority is executing on our strategy to accelerate the development and delivery of transformative medicines for patients, and we are confident that we can accomplish ...
Johnson & Johnson (NYSE:JNJ) Shares Bought by Islay Capital Management LLC
ETF DAILY NEWS· 5 days agoIslay Capital Management LLC grew its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 14.4% during the fourth quarter, according to the company in its most recent disclosure with the ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Wealthcare Advisory Partners LLC
ETF DAILY NEWS· 7 hours agoWealthcare Advisory Partners LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent filing with the Securities ...
Q3 2024 EPS Estimates for Johnson & Johnson (NYSE:JNJ) Cut by Analyst
ETF DAILY NEWS· 8 hours agoJohnson & Johnson (NYSE:JNJ – Free Report) – Investment analysts at Zacks Research lowered their Q3 2024 earnings estimates for shares of Johnson & Johnson in a research note issued on Tuesday ...
Spire Wealth Management Sells 5,652 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 8 hours agoSpire Wealth Management lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 13.6% during the fourth quarter, HoldingsChannel reports. The firm owned 35,894 shares of ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 7 days agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...
Malaga Cove Capital LLC Acquires New Shares in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoMalaga Cove Capital LLC bought a new position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the ...